Soleno Therapeutics is Diagnostic Equipment in United States that focus on Soleno Therapeutics Inc business. Founded in 1999. They cover business area such as Soleno Therapeutics Inc, commercialization, novel therapeutic, rare disease, its product candidate, Diazoxide Choline Controlled-Release tablet, an oral tablet, Prader-Willi Syndrome.
1999
( 25 years old in 2024 )
Soleno Therapeutics Inc
-
203 Redwood Shores Parkway
Suite 500
Redwood City, CA 94065
United States
Private
Soleno Therapeutics Inccommercializationnovel therapeuticrare diseaseits product candidateDiazoxide Choline Controlled-Release tabletan oral tabletPrader-Willi Syndrome
* We use standard office opening hours in near Soleno Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Soleno Therapeutics is Diagnostic Equipment business from United States that founded in 1999 (25 years old in 2024), Soleno Therapeutics business is focusing on Soleno Therapeutics Inc.
Soleno Therapeutics headquarter office and corporate office address is located in 203 Redwood Shores Parkway Suite 500 Redwood City, CA 94065 United States.
Soleno Therapeutics was founded in United States.
In 2024, Soleno Therapeutics is currently focus on Soleno Therapeutics Inc sector.
Above is snippet of Google Trends for "Soleno Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Soleno Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
